Estrogen and progesterone receptors in human papilloma virus-related cervical neoplasia.
Estrogen (ER) and progesterone (PR) receptors in the normal uterine cervix, cervical intraepithelial neoplasia and invasive carcinoma were studied in consecutive samples from Hospital do Cáncer, São Paulo, between 1996 and 1997. Tissue was collected by removing a fragment of the tumoral area using a 5-mm diameter biopsy punch, followed by removal of a macroscopically normal area as close as possible from the tumor. Histopathological confirmation was obtained for all specimens analyzed. A total of 24 normal tissues, 17 cases of cervical intraepithelial neoplasia and 7 of invasive carcinomas were studied. The ER/PR ratio was determined by immunohistochemistry using monoclonal antibodies specific for each receptor. Adjacent tissue slides were submitted to generic PCR for human papillomavirus (HPV) DNA detection followed by typing by dot blot hybridization. About half (45.8%) of the tumors were HPV DNA positive while 29.1% of the patients were also HPV positive in their respective normal tissue. ER was negative in the tumoral epithelium of 11 HPV-positive patients (P=0.04). There was a trend in the ER distribution in normal tissue that was opposite to that from lesions, but it was not statistically significant (P=0.069). No difference in ER distribution in stromal tissues was observed between HPV-positive and HPV-negative tissues. PR staining was negative in the epithelium of all cases studied. The results obtained from this small number of cases cannot be considered to be conclusive but do suggest that factors related to viral infection affect the expression of these ER/PR cervix receptors.
Coelho
F R G
FR
Departamento de Ginecologia, Hospital do Câncer, Fundação Antonio Prudente, São Paulo, SP, Brasil. frgcoelho@lexxa.com.br
Prado
J C M
JC
Pereira Sobrinho
J S
JS
Hamada
G
G
Landman
G
G
Pinto
C A
CA
Nonogaki
S
S
Villa
L L
LL
D000328:Adult; D002277:Carcinoma / Q000737:chemistry* / Q000821:virology; D002584:Cervix Uteri / Q000737:chemistry / Q000821:virology; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000150:complications*; D016133:Polymerase Chain Reaction; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*; D002583:Uterine Cervical Neoplasms / Q000737:chemistry* / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000737:chemistry* / Q000821:virology
D004279:DNA, Viral; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone